Valuation: CODON

Market Cap 657K 752K 618K 564K 1.06M 71.91M 1.06M 7.42M 2.86M 36.72M 2.83M 2.76M 118M P/E 2021
-4.36x
P/E 2022 -0.3x
Enterprise Value 1.58M 1.81M 1.49M 1.36M 2.55M 173M 2.55M 17.87M 6.9M 88.51M 6.81M 6.66M 285M EV / Sales 2021
3.94x
EV / Sales 2022 1.09x
Free-Float
35.8%
Yield 2021 *
-
Yield 2022 -
Manager TitleAgeSince
Chief Executive Officer 62 15/01/2020
Investor Relations Contact - -
Director TitleAgeSince
Chairman - 28/04/2022
Director/Board Member - 06/07/2010
Director/Board Member 82 11/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+1.07%+4.27%+35.50%-2.14% 79.7B
+5.02%+25.59%+579.80%+80.57% 69.04B
+1.36%+5.33%-8.90%-29.50% 60.82B
-0.78%-2.04%-11.65%+27.42% 47.16B
+0.66%+1.72%+3.39%+159.99% 46.38B
+2.39%+3.71%+59.38%-13.00% 32.37B
+1.16%+3.33%+48.47%+116.52% 25.27B
+0.68%+6.45%+12.00%+172.03% 22.72B
+1.04%+1.96%+59.16%+103.91% 15.7B
Average +1.41%+3.26%+86.35%+68.42% 44.35B
Weighted average by Cap. +1.63%+4.22%+115.93%+51.04%

Financials

2021 2022
Net sales 9.8M 11.22M 9.21M 8.41M 15.78M 1.07B 15.78M 111M 42.67M 548M 42.13M 41.2M 1.77B 6.24M 7.14M 5.87M 5.35M 10.05M 683M 10.05M 70.4M 27.17M 349M 26.82M 26.23M 1.12B
Net income -9.32M -10.67M -8.76M -8M -15.01M -1.02B -15.01M -105M -40.58M -521M -40.06M -39.18M -1.68B -16.98M -19.43M -15.96M -14.56M -27.33M -1.86B -27.34M -192M -73.91M -949M -72.97M -71.37M -3.06B
Net Debt -293K -335K -275K -251K -472K -32.05M -472K -3.31M -1.28M -16.37M -1.26M -1.23M -52.77M 927K 1.06M 871K 795K 1.49M 101M 1.49M 10.46M 4.03M 51.79M 3.98M 3.9M 167M
Logo CODON
CoDon AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. It also offers biopsy, cultivation, transplantation, rehabilitation and others.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!